ArticleScientific reports2019

Adverse effects of dasatinib on glucose-lipid metabolism in patients with chronic myeloid leukaemia in the chronic phase.

Lu Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.